Stanford University
Showing 6,201-6,300 of 7,778 Results
-
Shebani Sethi MD, ABOM
Clinical Associate Professor, Psychiatry and Behavioral Sciences
Current Research and Scholarly InterestsImproving metabolic and mental health through dietary metabolic therapies, pharmacological optimization, and other lifestyle interventions in those with severe mental illness, such as bipolar disorder, schizophrenia, major depression is a major focus of her research. Clinical and academic interests include management of psychiatric disorders with co-morbid obesity, insulin resistance, metabolic dysfunction and/or eating disorders, particularly binge eating disorder and bulimia nervosa.
-
Kawin Setsompop
Professor of Radiology (Radiological Sciences Laboratory) and, by courtesy, of Electrical Engineering
BioKawin Setsompop is a Professor of Radiology and, by courtesy, of Electrical Engineering. His research focuses on the development of novel MRI acquisition methods, with the goal of creating imaging technologies that can be used to help better understand brain structure and function for applications in Healthcare and Health sciences. He received his Master’s degree in Engineering Science from Oxford University and his PhD in Electrical Engineering and Computer Science from MIT. Prior to joining Stanford, he was a postdoctoral fellow and subsequently a faculty at the A.A. Martinos center for biomedical imaging, MGH, as well as part of the Harvard and MIT faculty. His group has pioneered several widely-used MRI acquisition technologies, a number of which have been successfully translated into FDA-approved clinical products on Siemens, GE, Phillips, United Imaging and Bruker MRI scanners worldwide. These technologies are being used daily to study the brain in both clinical and neuroscientific fields.
-
Shaun P. Setty
Clinical Assistant Professor, Cardiothoracic Surgery
BioDr. Setty is Surgical Director of the Cardiac Intensive Care Unit, Director of Global Cardiac Care, and a member of the pediatric cardiac surgery team. Dr. Setty completed his general surgery residency at Oregon Health Sciences University and spent an infolded year during his training at Green Lane Hospital in New Zealand as a research and pediatric/ adult cardiac surgery fellow. He then spent 3 years at the University of Minnesota/ Lillehei Heart Institute, the birthplace of cardiac surgery, completing his cardiothoracic surgery training. He performed his congenital heart surgery fellowship at the Royal Children’s Hospital in Melbourne, Australia. Dr. Setty is triple-board-certified in surgery, thoracic surgery, & congenital heart surgery. He has past experience in all aspects of pediatric and adult congenital cardiac surgery including neonatal and transplant surgery. He is a member of the medical school honor society, Alpha Omega Alpha. Dr. Setty also has numerous peer-reviewed publications, book chapters, and research presentations to his credit.
His current research focus includes: cardiac surgery outcomes with genetic syndromes, social determinants of health and its effect on cardiac surgery outcomes, big data in international cardiac surgery humanitarian centers, and the epigenetic delineation of congenital heart disease. -
Sharon Sha, MD, MS
Clinical Professor, Adult Neurology
BioDr. Sha is a Clinical Professor of Neurology and Neurological Sciences at Stanford University where she serves as Chief for the Memory Disorders Division and the Stanford Memory Disorders Center, Associate Vice Chair of Clinical Research, Director of the Huntington’s Disease Center of Excellence and Ataxia Clinic, Co-Director of the Lewy Body Disease Association Research Center of Excellence, and Clinical Core Co-Leader of the Stanford Alzheimer's Disease Research Center. Her clinical time is devoted to caring for patients with Alzheimer’s disease and other neurodegenerative disorders and her research is devoted to finding treatments for these cognitive disorders. She also served on the California Governor’s Alzheimer’s Prevention and Preparedness Task Force Chaired by Maria Shriver in 2020. She has been featured in international media and documentaries such as the BBC "How to Stay Young" and the Docuseries "Limitless with Chris Hemsworth".
-
Ross Shachter
Associate Professor of Management Science and Engineering
Current Research and Scholarly InterestsProf. Shachter's research has focused on the representation, manipulation, and analysis of uncertainty and probabilistic reasoning in decision systems. As part of this work, he developed the DAVID influence diagram processing system for the Macintosh. He has developed models scheduling patients for cancer follow-up, and analyzing vaccination strategies for HIV and Helobacter pylori.
-
Audrey Shafer
Professor of Anesthesiology, Perioperative and Pain Medicine, Emeritum
Current Research and Scholarly Interestsliterature and medicine, humanistic aspects of medicine and anesthesia care, language and medicine, communication, medical humanities, creative writing, arts and healthcare
-
Robert W. Shafer
Professor (Research) of Medicine (Infectious Diseases) and, by courtesy, of Pathology
Current Research and Scholarly InterestsMy group’s research is on the mechanisms and consequences of virus evolution with a focus on HIV therapy and drug resistance. We maintain a public HIV drug resistance database (http://hivdb.stanford.edu) as a resource for HIV drug resistance surveillance, interpreting HIV drug resistance tests, and HIV drug development. Our paramount goal is to inform HIV treatment and prevention policies by identifying the main factors responsible for the emergence and spread of drug resistance.
-
Steven L. Shafer, MD
Professor of Anesthesiology, Perioperative and Pain Medicine (Adult MSD) at the Stanford University Medical Center, Emeritus
Current Research and Scholarly InterestsPharmacokinetics and pharmacodynamics of intravenous anesthetics, including drug interactions and continuous measures of drug effect; model-based drug development; target controlled drug delivery; advanced models of drug behavior.
-
Ami J. Shah
Clinical Professor, Pediatrics - Stem Cell Transplantation
BioDr. Shah joined Stanford University in 2015 as a Clinical Professor of Pediatrics in the Division of Hematology/ Oncology, Stem Cell Transplantation and Regenerative Medicine. Dr. Shah completed medical school at the University of North Carolina- Chapel Hill. She completed her training in Pediatrics and Pediatric Hematology/ Oncology at Childrens Hospital Los Angeles. Her areas of clinical expertise have been in stem cell transplantation for malignant and non-malignant disorders. She has been actively involved with the care and treatment of children with primary immune deficiencies and is the site PI for the Primary Immune Deficiencies Consortium (PIDTC). She has experience in numerous gene therapy trials for primary immune deficiencies, hemoglobinopathies and other genetic diseases. She has a specific interest in the long term outcomes following HSCT, in specific the neurocognitive function post HSCT. She has been an active participant in American Society of Transplantation and Cellular Therapy (ASTCT), Children's Oncology Group (COG) and American Society of Hematology (ASH).
She has been actively involved with mentorship and graduate medical education, and currently serves as the Program Director for the Pediatric Hematology/ Oncology Fellowship and the Pediatric Stem Cell Fellowship. She also serves on the Pediatric Mentoring Group. -
Mamta Madhav Shah, MD
Clinical Assistant Professor, Medicine - Nephrology
BioDr. Shah is a board-certified, fellowship-trained nephrologist and clinical assistant professor in the Department of Medicine, Division of Nephrology at Stanford University School of Medicine.
She provides care for patients with a variety of kidney-related conditions, with a special interest in management of kidney stones and related conditions. Her goal is to collaborate with each patient to develop a personalized and comprehensive care plan. She has given several talks on kidney stones to trainees and peers. Dr. Shah previously served as medical director of one of the dialysis clinics at University of Connecticut Health Center and helped run the plasmapheresis treatments.
Some of Dr. Shah’s recent research is focused on efforts to prevent filter failure when performing membrane-based therapeutic plasma exchange—a blood purification treatment for removing large molecular weight substances from plasma.
Dr. Shah’s work has been published in the Journal of Onco-Nephrology, Therapeutic Apheresis and Dialysis, and Connecticut Medicine. She has presented to her peers at national and regional meetings of the American Society of Nephrology, the National Kidney Foundation, and the American College of Physicians, Connecticut Chapter.
Dr. Shah is a member of the American Society of Nephrology. She has a keen interest in education of trainees including medical students, residents and fellows; and served as core faculty of the Nephrology Fellowship at the University of Connecticut Health Center.
She is fluent in Hindi and Gujarati. Outside of work she enjoys traveling and spending time with her husband and daughter. -
Manish I. Shah, MD, MS
Professor of Emergency Medicine (Pediatrics) and, by courtesy, of Pediatrics (Hospital Medicine)
BioI have dedicated my career to improving pediatric prehospital care on local, statewide, national, and international levels through research, education, and advocacy. My primary research interest focuses on integration of pediatric evidence into emergency medical services (EMS) systems. I serve on the Executive Committee of the Pediatric Emergency Care Applied Research Network (PECARN) as the nodal Principal Investigator (PI) for the Charlotte, Houston, and Milwaukee Prehospital (CHaMP) research node. In addition, I am the PI for the Pediatric Dose Optimization for Seizures in EMS (PediDOSE) clinical trial and co-investigator for the Pediatric Prehospital Airway Resuscitation Trial (Pedi-PART). As an educational researcher, I have obtained several grants to produce an online EMS educational resource for physicians, create the Pediatric Simulation Training of Emergency Prehospital Providers (PediSTEPPs) program, and study the implementation of an EMS training curriculum for the Botswana Ministry of Health. As an EMS advocate, I led the Prehospital and State Partnership domains for the national EMS for Children (EMSC) Innovation and Improvement Center (EIIC), served as an appointed member of the National Emergency Medical Services Advisory Council (NEMSAC), chaired the EMS subcommittee for the American Academy of Pediatrics Section of Emergency Medicine, and directed the EMSC State Partnership in Texas. I have published policy on pediatric readiness in EMS systems and co-chaired the workgroup that created the first-ever national assessment of pediatric readiness of EMS systems for the National Prehospital Pediatric Readiness Project (PPRP).
-
Mona D. Shah, MD, MBA
Adjunct Clinical Associate Professor, Pediatrics - Hematology & Oncology
BioDr. Mona Shah is a pediatric hematologist-oncologist, who earned her MD degree at the University of Maryland in 2001. She completed both her categorical pediatrics and global health residencies in 2004, followed by a pediatric hematology-oncology fellowship in 2007. She earned her MS in Clinical Investigation as part of the Clinical Scientist Training Program (CSTP) at Baylor College of Medicine in 2011, and more recently, completed an Executive MBA at Rice University Jones School of Business in 2018.
Dr. Shah was an Associate Professor at Baylor College of Medicine (2007 - 2020) in both Pediatrics and Medicine, local site PI on a number of pediatric hemostasis/thrombosis clinical trials, and spent 10 years as an Associate Medical Director of Clinical Operations, Quality, and Safety at Texas Children’s Hospital, Houston, TX.
Dr. Shah joined Genentech (a Member of the Roche Group)’s Rare Blood Disorders Franchise (Product Development - Oncology-Hematology) in February 2020, quickly advancing to Lead Medical Director, where she served as Medical Monitor for 2 Phase III Clinical Trials (crovalimab in atypical hemolytic uremic syndrome, aHUS). She was also engaged with the Renal Franchise (I2O) in developing crovalimab in Lupus Nephritis (Phase I & II Clinical Trials in development), and with Human Factors/Pediatric Formulations Working Group on autoinjector devices and oral formulations.
After completing a rotation in Early Development Safety (EDS), she was promoted to Senior Medical Safety Director in Late Stage Product Development, and was appointed Safety Strategy Lead for giredestrant in early and metastatic breast, ovarian, and endometrial cancer global clinical trials. She has experience in innovative study designs (adaptive/multi-drug), with FDA/EMA pediatric investigational plans, and health authority interactions. In June 2023, she was appointed Pediatric Safety Lead, in collaboration with the iPODD Team, supporting safety for pediatric indications and devices, and serves as the Co-Chair of the Pediatric Safety Expert Group.
Dr. Shah has kept and completed a bucket list since she was 7 years old (keeps growing): Running wild bouldering/rock climbing as a child in the Shenandoah/Blue Ridge Mountains, swimming with dolphins/piranhas in the Amazon, climbing inside a volcano caldera in Iceland, snorkeling the Great Barrier Reef ... have passport/will travel!
Since July 2022, she has joined Stanford University School of Medicine, as an Adjunct Clinical Associate Professor in the Department of Pediatrics, Division of Hematology-Oncology, where she enjoys teaching MSII students, and at the bedside in the Lucille Packard Bass Center Hematology Clinic. Dr. Shah enjoys free time in her new home base near San Francisco, where she hosts her visiting parents, friends, and extended family. -
Neha Shah
Clinical Assistant Professor, Medicine - Immunology & Rheumatology
BioDr Shah's clinical and research interests lie in Integrative Rheumatology, healing-oriented medicine that takes account of the whole patient, including all aspects of lifestyle. It emphasizes the therapeutic relationship between practitioner and patient, is informed by evidence, and makes use of all appropriate therapies, including those outside the realm of allopathic medicine. Specifically, she is interested in exploring the impact of diet/nutrition/botanicals on inflammation as it pertains to rheumatic diseases such as gout, rheumatoid arthritis, lupus, psoriatic arthritis and other autoimmune conditions, as well as studying the impact of other lifestyle approaches such as mindful meditation, sleep, yoga, stress reduction, etc. on disease burden and quality of life of patients with rheumatic diseases. She boarded in Lifestyle Medicine and has advanced training in Functional Medicine. Dr Shah is currently pursuing additional training in Ayurvedic Medicine.
-
Nigam H. Shah, MBBS, PhD
Professor of Medicine (Biomedical Informatics) and of Biomedical Data Science
Current Research and Scholarly InterestsWe answer clinical questions using aggregate patient data at the bedside. The Informatics Consult Service (https://greenbutton.stanford.edu/) put this idea in action and led to the creation of Atropos Health. We build predictive models that allow taking mitigating actions, keeping the human in the loop.
-
Nirao Shah
Professor of Psychiatry and Behavioral Sciences (Major Laboratories and Clinical Translational Neurosciences Incubator), of Neurobiology and, by courtesy, of Obstetrics and Gynecology
Current Research and Scholarly InterestsWe study how our brains generate social interactions that differ between the sexes. Such gender differences in behavior are regulated by sex hormones, experience, and social cues. Accordingly, we are characterizing how these internal and external factors control gene expression and neuronal physiology in the two sexes to generate behavior. We are also interested in understanding how such sex differences in the healthy brain translate to sex differences in many neuro-psychiatric illnesses.
-
Nirav R. Shah, MD, MPH
Adjunct Professor, Medicine - Primary Care and Population Health
BioNirav R. Shah, MD, MPH, is Senior Scholar at Stanford University’s School of Medicine. He is a distinguished healthcare leader with experience as an operator, scientist, innovator, and regulator. His expertise spans public health, digital health and generative AI, public and private health insurance, and clinical operations across the continuum of care. At Stanford, Dr. Shah conducts research on improving healthcare quality and safety while lowering cost, driving adoption of digital technologies, and quantitatively evaluating the resulting value for US and international health care systems. Dr. Shah is Board-certified in Internal Medicine and is a graduate of Harvard College and Yale School of Medicine. He is an Advisor to the CDC Director, Senior Fellow of the Institute for Healthcare Improvement (IHI), independent director of STERIS plc [NYSE:STE], and trustee of the John A. Hartford Foundation. Previously, he served as Chief Operating Officer of Kaiser Permanente in Southern California, and as Commissioner of the New York State Department of Health.
-
Ripal Shah
Clinical Associate Professor, Psychiatry and Behavioral Sciences
BioRipal Shah, M.D., M.P.H. is a Clinical Associate Professor in the Department of Psychiatry & Behavioral Sciences. She specializes clinically in reproductive psychiatry (the Women's Wellness Clinic - pre-conception, pregnancy, postpartum, breastfeeding, fertility, pre-menstrual dysphoric disorder (PMDD), reproductive and sexual health disorders), lifestyle and integrative approaches to health (the Stanford Center for Integrative Medicine - vitamins, supplements, exercise, behavioral modifications, hypnosis), and in high performers such as physician wellness (the WellConnect program - serving Stanford resident/fellow/faculty physicians). Dr. Shah is regarded as one of the world's experts in PMDD, and one of very few specifically studying PMDD in women of color.
Her research areas of focus are on women's reproductive psychiatry, integrative approaches to mental health, ethnicity-dependent variability in mental health access and treatment response, psychedelics, spirituality, minority stress, and the role of Eastern religions on mental health in the U.S. Outside of consultations, she specializes in psychotherapy for minority populations, particularly those struggling with relationships or loss of a partner; grief or loss of a parent, sibling, child, or partner; issues related to identity (religious identification, racial/ethnic minority stress, racial trauma, professional transitions, changes in family structure or relational status, sexual orientation); as well as cognitive-behavioral therapy for ADHD and anxiety disorders. She has received specialized training in working with Black and South Asian populations.
While in training at Stanford, she served as Chief Resident and led community partnerships and DEI efforts. She consistently ranked #1 in the Stanford residency (and top 1% in the nation) on the annual knowledge-based examination (PRITE). She is a Disaster Mental Health Responder both domestically and internationally, volunteering after wildfires, hurricanes, and earthquakes. She founded and led the Diversity & Inclusion Advisory Council (DIAC) for psychiatry faculty and residents which is now a model organization for programs across the country, built and then graduated from a Diversity & Health Equity track in the residency, and created the first known Diversity & Health Equity Grand Rounds series. She served as Chair of the Chief Residents’ Council, representing over a thousand physicians to the Stanford Health Care leadership. Before her time at Stanford, she completed an M.P.H. at Harvard University in Health Care Management and Policy, an M.D. from the Mount Sinai School of Medicine in New York with tuition merit scholarship, and a B.S. from Duke University in Economics and Biochemistry.
She is board certified in Adult Psychiatry, Addiction Medicine, Obesity Medicine, and Integrative Medicine. She pursued additional training in the fields of Emergency Medicine and Internal Medicine, which has informed her evidence-based approach to integrative medicine. She has been credentialed in TMS (transcranial magnetic stimulation), ECT (electroconvulsive therapy), hypnosis, and ketamine infusions. She completed a Certificate in Psychedelic-Assisted Therapies and Research, with training from the Multidisciplinary Association for Psychedelic Studies (MAPS), and also completed MAPS' program MDMA Assisted Therapy Researcher Training. She is on the MDMA Clinical/Monitoring Team for Stanford's Pilot Study of 3,4-Methylenedioxymethamphetamine (MDMA)-Assisted Cognitive Behavior Therapy for Obsessive Compulsive Disorder: (MDMA+CBT-4-OCD). She advises several companies and research teams on the clinical use of psychedelics in psychiatry, and often consults with media and tech companies as an industry expert. She has been seen in TIME, Forbes, and the Washington Post, and in 2020 was awarded one of the top 25 rising stars in medicine by Medscape. -
Sajan Shah, MD, MBA
Clinical Assistant Professor, Anesthesiology, Perioperative and Pain Medicine
BioDr. Sajan Shah is a board-certified, fellowship-trained pain management specialist with the Stanford Health Care Pain Management Center. He is also a clinical assistant professor in the Department of Anesthesiology, Perioperative and Pain Medicine, Division of Pain Medicine at Stanford University School of Medicine.
Dr. Shah specializes in managing acute and chronic pain. He commonly cares for people living with complex spinal conditions that have not responded to conventional treatment. He offers a range of injections to manage pain, including joint corticosteroid injections, peripheral nerve blocks, trigger point injections, and Botox injections for migraines and dystonia. He has experience with neuromodulation techniques, including spinal cord stimulation and peripheral nerve stimulation, and minimally invasive spinal procedures. He strives to provide effective pain therapies that improve the everyday function and quality of life of his patients.
Dr. Shah’s research has explored topics in anesthesiology and pain medicine. He has studied chronic pain syndromes, including how to diagnose and manage rare pain conditions. Dr. Shah has published his findings in several peer-reviewed journals and co-authored a book chapter on complex regional pain syndrome. He has presented his research at national and international meetings, including those held by the American Academy of Pain Medicine, American Society of Regional Anesthesia and Pain Medicine, and North American Neuromodulation Society. -
Sejal Shah
Clinical Associate Professor, Pediatrics - Endocrinology
Current Research and Scholarly InterestsMy primary research interest is evaluating whether vitamin D supplementation can positively affect consequences of the metabolic syndrome in overweight and obese adolescents. Other research interests include evaluating the efficacy and biochemical profiles of various types of estrogen replacement in adolescent females.
-
Sumit Shah
Clinical Associate Professor, Medicine - Oncology
Clinical Associate Professor (By courtesy), UrologyBioDr. Sumit Shah is a medical oncologist specializing in the management of advanced urologic malignancies, including prostate, kidney, bladder, and testicular cancers. He serves as an investigator on numerous clinical trials, with a particular focus on novel immunotherapy agents. His academic interests also encompass digital health technologies and innovative healthcare delivery models, both domestically and internationally.
Dr. Shah graduated with distinction in biomedical engineering from Duke University, earned his MD from Stanford University, and completed a Master of Public Health at Harvard University. He trained in internal medicine at the University of California, San Francisco (UCSF), where he remained on faculty for one year before returning to Stanford for his fellowship in medical oncology. He now holds a faculty position in the Department of Medicine (Oncology) at Stanford.
In addition to his clinical and research roles, Dr. Shah serves as Medical Director of Digital Health Integration and Director of Infusion Services at Stanford Hospital. He is also Assistant Dean of Academic Advising in the Stanford School of Medicine. -
Jay Shah
Associate Professor of Urology
BioDr. Jay Shah, MD currently serves as Chief of the Medical Staff for Stanford Health Care. He is a cancer surgeon and associate professor of Urology at the Stanford University School of Medicine. His clinical focus is on bladder cancer, and he is well known for his expertise in robotic surgery. His academic interests center on optimizing outcomes after bladder removal surgery. He is very active in leadership development, team building, and quality improvement work and he lectures nationally and internationally on these topics. He is also certified by the International Coaching Federation as an executive coach.
Dr. Shah graduated from Harvard College, and he completed medical school and urology residency training at Columbia University. During his time at Columbia, Dr. Shah was elected to the Alpha Omega Alpha Medical Honor Society; he was named Physician of the Year by the nursing staff; and he was recognized by the medical students with the Gold Foundation Excellence in Teaching Award. After residency, he completed a three-year fellowship in Urologic Oncology at MD Anderson Cancer Center and then joined the faculty there. During his time at MD Anderson, Dr. Shah launched the bladder cancer robotics program, developed an enhanced recovery program for patients undergoing bladder removal surgery, became double board-certified in Urology and Medical Quality, and was chosen to lead the MDACC Genitourinary Center as Center Medical Director.
In his free time, Dr. Shah enjoys reading, cooking, and exploring the beaches of Northern California with his family and three dogs.
In his free time, Dr. Shah enjoys reading, cooking, surfing, hiking and exploring the beaches of Northern California in his Jeep Wrangler with his family and 2 dogs. -
Shagufta Shaheen
Clinical Assistant Professor, Medicine - Oncology
BioDr. Shaheen specializes in the gastrointestinal malignancies and she has expertise in treating neuroendocrine tumors (NETs). Following her fellowship in Hematology and Oncology, Dr Shaheen completed an advanced fellowship in Neuroendocrine tumors from Stanford University. The NET advanced fellowship is first of its kind in United State started under the leadership of Dr Pamela Kunz who is the founding Director of the Stanford Neuroendocrine Tumor Program established in 2015. After completing her advanced fellowship, Dr Shaheen joined Stanford Oncology division as Clinical Assistant Professor. Dr Shaheen is involved in further developing the neuroendocrine oncology program at Stanford which serves as a centre of excellence in the treatment of neuroendocrine tumors. Dr Shaheen is actively involved in clinical research and clinical trials. Dr Shaheen is also involved in taking care of patients admitted to the oncology service as well as resident and fellow teaching.
-
Mohammad Shahrokh Esfahani
Assistant Professor of Radiation Oncology (Radiation and Cancer Biology)
BioWith a primary focus on high-dimensional data, I have significant expertise in developing machine learning tools. Much of my work involves constructing Bayesian models, which effectively convert 'prior knowledge', either inherent in the dataset or obtained from external sources, into mathematical terms—more specifically, prior probabilities.
My recent research efforts have centered on the analysis of genetic and epigenetic signals within cell-free DNA assays. This interest in epigenetics led to the development of a pioneering technique known as EPIC-seq, which has broadened our understanding of this complex field.
It's notable that traditional computational methods in cancer genomics often fall short when confronted with an exceedingly low signal-to-noise ratio—a common scenario in cfDNA analyses. As such, there's an emerging need to devise innovative, robust methods capable of overcoming this limitation—a research area that I'm deeply committed to and actively engaged in. -
Cory Shain
Assistant Professor of Linguistics and, by courtesy, of Psychology
BioI lead the Laboratory for Computation & Language in Minds & Brains (CLiMB Lab). We try to figure out how our brains let us go so efficiently from sensation (e.g., speech, reading) to meaning, and we do this using a combination of neuroimaging, computer modeling, and behavioral experiments. See the lab website for details.
-
Mehrdad Shamloo
Professor (Research) of Neurosurgery and, by courtesy, of Neurology and Neurological Sciences
Current Research and Scholarly InterestsThe ultimate goal of the Shamloo laboratory is to rapidly advance our understanding of brain function at the molecular, cellular, circuit and behavioral levels, and to elucidate the pathological process underlying malfunction of the nervous system following injury and neurologic disorders such as stroke, Alzheimer's disease, Parkinson’s disease, and autism. We have been focusing on the noradrenergic system and approaches leading to restoration of brain adrenergic signaling in these disorders.
-
Hua Shan
Professor of Pathology
BioDr. Shan specializes in providing blood transfusion and apheresis treatment to patients with diverse medical problems. She has been practicing transfusion medicine for over twenty five years. Dr. Shan currently serves as the Medical Director of Transfusion Service at Stanford Medical Center. Dr. Shan has also been leading research and education programs in the fields of transfusion safety, optimizing clinical blood transfusion practice and blood availability.
-
Vikram Shankar, MD
Clinical Instructor, Ophthalmology
BioDr. Shankar, MD, MPH, is a board-certified, fellowship-trained ophthalmologist at the Stanford Health Care Byers Eye Institute. He is also a clinical instructor in the Department of Ophthalmology at Stanford University School of Medicine.
Dr. Shankar’s clinical focus is the medical and surgical care of cataracts and adult glaucoma, including premium lenses and minimally invasive glaucoma surgery (MIGS). Dr. Shankar’s research and professional interests include ophthalmic public health, biomedical devices, and digital health. He has a particular interest in the intersection of entrepreneurship, public health, and ophthalmology, aiming to find innovative solutions that will impact millions of patients.
Dr. Shankar has published research on lung cancer metastasis to the optic nerve, pharmacologic therapies in glaucoma, and surgical outcomes with a novel glaucoma device. He has also delivered presentations nationwide on topics including screening rates for diabetic retinopathy based on insurance type and socioeconomic factors, Medicaid expansion, and health disparities.
Dr. Shankar completed a combined MD/MPH at Washington University in St. Louis School of Medicine. He earned the Albert F. Koetter, MD Scholarship; Dean’s Research Fellowship; and Jonathan Mann Fellowship as a medical student. He completed his ophthalmology residency at the Wills Eye Hospital in Philadelphia, PA. He subsequently completed his fellowship in glaucoma at the Stanford Byers Eye Institute.
Dr. Shankar is the cofounder of a seed-stage ophthalmic medical device startup that aims to improve patient safety and mitigate the environmental impact of eye care worldwide.
Dr. Shankar is a member of the American Academy of Ophthalmology. -
Michael Shanks
Professor of Classics
BioProfessor at Stanford University, Michael Shanks is one of the most original and influential of contemporary archaeologists. He has been at the forefront of archaeological thought and practice since the 1980s, pioneering new ways of understanding and explaining, engaging with Graeco-Roman antiquity and European prehistory, mobilizing remains of the past all around us — instigating changes in archaeology and how we all work with remains of the past. A specialist in long-term perspectives on design and creativity, innovation and social change, he explores connections across the sciences, humanities, and arts in research collaborations and outreach through and beyond the academy, tapping more than $32m of funding over the last 25 years.
Current projects
MS is currently completing four long-running and interrelated projects.
Archaeological history — building scenarios.
Greece and Rome: a new model of antiquity. With Gary Devore. A project concerned with how one might conceive of antiquity as a kind of archaeological prehistory, retold through speculative fabulation. Against conventional narrative is offered a model of ancient lifeworlds conveyed through 45 personae and scenarios. Estimated delivery end of 2026.
Archaeological sites — encountering location.
Against place: a border archaeology. Based on archaeological itineraries in the northern borders of England/Scotland, including prehistoric and Roman field research, this project explores border crossings, trespass and transgression in questioning the character of space and place, site and region. Estimated delivery 2027.
Archaeological praxis — performance design.
Theatre/Archaeology: performing remains. With Mike Pearson. This book sums up 30 years of collaboration with performance artist Mike Pearson. In five portfolios of case studies in performance design they set out a pragmatics and methodology of deep mapping contemporary antiquity and prehistory. Estimated delivery end of 2025.
Archaeological actuality — for the future.
Archaeologies of Nature in Art: from Landscape to Climate Breakdown. With Gabriella Giannachi. This project mobilizes an archaeology of arts practices, from prehistory to contemporary art, to offer action-oriented responses to climate change in a reframing of the concept of nature. Estimated delivery autumn 2025.
The following is part of his continuing exploration of Applied Archaeology — design foresight.
Project Athena: Innovation in and through Learning. With Aisin Corporation led by Kenji Suzuki and in collaboration with Kimihiko Iwamura. Developing learning community and competencies in creative pragmatics — designing and implementing a strategy of corporate culture change. Ongoing 2025 – 2026. -
Lucy Shapiro
Virginia and D. K. Ludwig Professor, Emerita
Current Research and Scholarly InterestsA basic question in developmental biology involves the mechanisms used to generate the three-dimensional organization of a cell from a one-dimensional genetic code. Our goal is to define these mechanisms using both molecular genetics and biochemistry.
-
Eric S.G. Shaqfeh
Lester Levi Carter Professor and Professor of Mechanical Engineering
Current Research and Scholarly InterestsI have over 25 years experience in theoretical and computational research related to complex fluids following my PhD in 1986. This includes work in suspension mechanics of rigid partlcles (rods), solution mechanics of polymers and most recently suspensions of vesicles, capsules and mixtures of these with rigid particles. My research group is internationally known for pioneering work in all these areas.
-
Naima G. Sharaf
Assistant Professor of Biology and, by courtesy, of Structural Biology
Current Research and Scholarly InterestsResearch in the lab bridges biology, microbiology, and immunology to translate lipoprotein research into therapeutics
-
Paul Sharek MD, MPH
Professor of Pediatrics (Hospital Medicine) at the Lucile Salter Packard Children's Hospital, Emeritus
Current Research and Scholarly InterestsResearch interests centered on hospital based quality of care improvement, and in particular pediatric patient safety. Areas of recent interest include developing practical tools to more accurately identify adverse medical events and to establish national rates of these adverse events. Additional areas of interest focus on developing the processes and systems to decrease the frequency of adverse drug events and adverse medical events at Children's hospitals in North America
-
Husham Sharifi
Clinical Assistant Professor, Medicine - Pulmonary, Allergy & Critical Care Medicine
BioI am a Clinical Assistant Professor in the Division of Pulmonary, Allergy, and Critical Care Medicine in Stanford University School of Medicine. In addition to seeing patients in the intensive care unit (ICU), I focus my research and clinical practice on transplant-related pulmonary fibrosis, which includes fibrotic lung disease after lung transplant or after hematopoietic cell transplant. My research applies advanced computational analysis to clinical metadata and quantitative imaging data, domains that draw on my training in engineering and bioinformatics. In the clinical setting I see patients in a Lung Graft-versus-Host-Disease (GVHD) Clinic for individuals with pulmonary complications after life-saving hematopoietic cell transplant. Our clinic is part of a national Lung GVHD Consortium comprising Stanford, Fred Hutchinson Cancer Center, University of Michigan, and MD Anderson Cancer Center. In this context I am the site co-Principal Investigator for two national clinical trials through the Lung GVHD Consortium that are funded by the National Institutes of Health. The first trial uses a home spirometry device and monitoring system to study the association of Lung GVHD with respiratory viral infections. The second trial studies the diagnostic and prognostic utility of quantitative CT scans of the chest for Lung GVHD. My goal is to fuse detailed, communicative patient care with the advances of data science in medicine that I research and study.
See my website at https://www.sharifi.com/. -
Rahul P Sharma, MBBS, FRACP
Clinical Professor, Medicine - Cardiovascular Medicine
Current Research and Scholarly InterestsTranscatheter valve therapies, CT valve imaging, AI and device innovation
-
Christopher Sharp, MD
Clinical Professor, Medicine - Primary Care and Population Health
Current Research and Scholarly InterestsClinical Informatics
Clinical Education
Teaching Physical Examination
Quality Improvement
Preventive Medicine -
Carla Shatz
Sapp Family Provostial Professor and Professor of Biology and of Neurobiology
Current Research and Scholarly InterestsThe goal of research in the Shatz Laboratory is to discover how brain circuits are tuned up by experience during critical periods of development both before and after birth by elucidating cellular and molecular mechanisms that transform early fetal and neonatal brain circuits into mature connections. To discover mechanistic underpinnings of circuit tuning, the lab has conducted functional screens for genes regulated by neural activity and studied their function for vision, learning and memory.
-
Rich Shavelson
Margaret Jacks Professor of Education, Emeritus
Current Research and Scholarly InterestsAssessment of learning in higher education (including the Collegiate Learning Assessment); accountability in higher education; higher education policy.
-
Gary M. Shaw
Rosemarie Hess Professor and Professor (Research), by courtesy, of Epidemiology and Population Health and of Obstetrics and Gynecology (Maternal Fetal Medicine)
Current Research and Scholarly InterestsPrimary research interests include 1) epidemiology of birth defects, 2) gene-environment approaches to perinatal outcomes, and 3) nutrition and reproductive outcomes.
-
Jonathan Shaw
Clinical Professor (By courtesy), Obstetrics & Gynecology
Current Research and Scholarly InterestsPrimary care, psycho-social determinants of health & care, maternal-child health
-
Kate Shaw, MD MS
Associate Professor of Obstetrics and Gynecology (Gynecology & Gynecologic Specialties/Complex Family Planning)
Current Research and Scholarly InterestsMy research interests include expanding access to and and improving patient experience with contraception and abortion care both domestically and globally. I am also interested in medical education and resilience among physicians and trainees.
-
Richard J. Shaw, M.D.
Professor of Psychiatry and Behavioral Sciences (Child & Adolescent Psychiatry), Emeritus
Current Research and Scholarly InterestsPsychological issues in medically ill children.
Medical posttraumatic stress disorder.
Treatment adherence.
Transplant psychiatry.
Pediatric oncology.
Forensic psychiatry. -
Xinshu She
Clinical Associate Professor, Pediatrics
Current Research and Scholarly InterestsMy current interests include global mental health promotion in underserved pediatric populations, including refugee health in US-Mexico borders, minority mental health in the US, and parental mental health in low-middle-income countries. I am also interested in physician wellness and Diversity and Inclusion.
-
Kevin Shea
Chambers-Okamura Endowed Professor of Pediatric Orthopaedics
BioKevin G. Shea, MD is at Stanford University. He grew up in Montana and California, graduated from the University of Notre Dame, UCLA School of Medicine, and completed his orthopaedic residency at the University of Utah. His advanced training includes pediatric orthopaedics at Rady Children’s Hospital in San Diego, AO Fellowship in Bern Switzerland with Dr. Ganz (Hip), Dr. Diego Fernandez (Trauma), and Dr. Hans Staubli (sports), Ilizarov Training in Lecco, Italy. He has done the AOSSM South American Traveling Sports Medicine Fellowship, and education in Russia and former Soviet Bloc countries. Most of his early career was in Boise, Idaho. Dr. Shea is a founding member of the PRISM Society (Pediatric Research in Sports Medicine) and the ROCK (Research in Osteochondritis Dissecans of the Knee) Multi-center Study Group, and the SCORE (Sports Cohort Outcomes Research ) Multi-Center Registry for pediatric sports. He has authored more than 300 scientific papers and chapters. His clinic research interests include cartilage and ligament disorders, using pediatric cadaveric tissue and surgical 3D simulations to develop surgeries and improve outcomes for procedures that avoid damage to growth plates. He has years of experience with performance, quality improvement, value, and he worked extensively with the AAOS Quality/Clinical Practice Guideline Committees. He is one of the POSNA members to launch the POSNA Safe Surgery Program. He is a national quality leader in health care with interests in patient safety, risk reduction, and improving value in health care with clinician integration into supply chain. He is an avid cyclist, trail runner, hiker, and spends as much time outside as possible, with his partner Lonnie and their children Beck and Cooper.
-
Alicia Myles Sheares
Assistant Professor of Management Science and Engineering and, by courtesy, of Sociology
BioProfessor Alicia Myles Sheares is an Assistant Professor in the Management Science and Engineering department at Stanford University. Her research sits at the intersection of race and organizations with a specific focus on how underrepresented professionals of color fare in the United States. Currently, she’s working on two major projects. The first explores the experiences of Black tech entrepreneurs in Silicon Valley and Atlanta, while the second explores individual and company-level factors that are associated with success among Black and Latine startups in the U.S. Her research has been published in Social Forces, the Sociology of Race and Ethnicity, Big Data and Society, and the International Migration Review. Professor Sheares was a University of California President’s Postdoctoral Fellow at UCLA. She received her Ph.D. in sociology from UC Berkeley, her M.Sc. in Migration Studies from the University of Oxford, and her B.A. from Spelman College.
Email: asheares@stanford.edu -
Clifford Sheckter, MD, MS, FACS
Assistant Professor of Surgery (Plastic and Reconstructive Surgery)
BioDr. Cliff Sheckter is a California native, growing up in the rural Eastern Sierra. He graduated from UCLA with a BS in Anthropology and earned summa cum laude and Phi Beta Kappa honors. He attended USC (Keck) for medical school on an academic scholarship and graduated valedictorian with Alpha Omega Alpha honors. He fell in love with burn care while at USC/LA General Medical Center and completed surgical training at Stanford. While in residency, he pursued a fellowship/postdoc in Health Systems Design at Stanford’s Clinical Excellence Research Center (CERC). He earned an MS in Health Policy from Stanford, focusing on health economics. He received additional training in Surgical Critical Care and Burn Surgery at the University of Washington.
Dr. Sheckter is a health services and health policy researcher. His work focuses on burn prevention and health economics in surgical care. He has authored over 150 articles and numerous book chapters. His research has been published in JAMA, JAMA Network Open, JAMA Surgery, Annals of Surgery, Journal of Plastic & Reconstructive Surgery, Burns, and Journal of Burn Care & Research. His work has been featured in USA Today and the New York Times. He was the recipient of a career development award from the NIH and has funding from the Plastic Surgery Foundation. Dr. Sheckter was awarded the American Burn Association (ABA) Traveling Fellow for 2023 and has won top abstract at the ABA Annual Meeting multiple times. He is an active member of the ABA and Chairs the Burn Prevention Committee.
Dr. Sheckter is one of a few surgeons double-board certified in Surgical Critical Care and Plastic & Reconstructive Surgery. He practices critical care medicine as an intensivist in the Stanford Surgical ICU. He is the Director of the Regional Burn Center at Santa Clara Valley Medical Center which is the only burn/trauma center for the San Francisco Bay Area. He performs scar reconstruction using surgical and laser techniques. -
Meera Sheffrin
Clinical Associate Professor, Medicine - Primary Care and Population Health
Current Research and Scholarly InterestsGeriatric education
Implementation and evaluation of home-based care
Improving care for older adults with dementia -
Javaid I. Sheikh
Professor of Psychiatry and Behavioral Sciences, Emeritus
Current Research and Scholarly InterestsMy research focuses on studying phenomenology, vulnerability factors, and psychiatric and medical comorbidity of panic disorder in old age, as well as treatment responses to medication in elders with panic disorder. I am presently involved in establishing and extending our preliminary finding that Late-Onset Panic Disorder (LOPD) (onset at or after age 55) is a phenomenologically distinct syndrome from Early-Onset Panic Disorder (EOPD).
-
Andrew A. Shelton, MD, FACS, FACRS
Clinical Professor, Surgery - General Surgery
Current Research and Scholarly InterestsMultimodality treatment of rectal cancer
Sphincter preserving procedures for rectal cancer
Laparoscopic colon and rectal surgery
Surgical education -
Dennis Shem
Clinical Assistant Professor, Surgery - Plastic & Reconstructive Surgery
BioDr. Shem is a Clinical Assistant Professor in the Section of Dental Medicine and Surgery at Stanford University. He trained in Dental Oncology at Memorial Sloan Kettering Cancer Center, focusing on oral complications of cancer therapy and non-surgical management of patients with osteoradionecrosis (ORN) and medication-related osteonecrosis of the jaw (MRONJ). He also trained in Oral and Maxillofacial Pathology at Columbia University and has expertise in diagnosing and managing oral mucosal diseases.
As a dental oncologist and oral pathologist, he evaluates patients before and after organ and stem-cell transplant, radiation therapy, chemotherapy, and bisphosphonate therapy. He has particular interest in oral manifestations of systemic disease, oral complications of systemic therapy, and oral dysplasia. -
Vered Karti Shemtov
Eva Chernov Lokey Senior Lecturer in Hebrew Language and Literature
BioSee bio at: https://dlcl.stanford.edu/people/vered-karti-shemtov
-
Prof Christopher Shen MD
Adjunct Professor, Medicine - Surgery
Academic Staff - Hourly - CSL, SurgeryBioDr. Christopher Shen is an Adjunct Professor in the Stanford School of Medicine, the Director of Global Programs at the Stanford Mussallem Center for Biodesign, and a member of the Stanford Biodesign Leadership Council. Dr. Shen is also the Founding Executive Director of the Singapore Stanford Biodesign Program.
Dr. Shen has been a longstanding member of the Stanford community since 1991, completing degrees in Biological Sciences, Biomechanical Engineering, Business, and Medicine. He has been teaching graduate and undergraduate students since 2001.
A strong proponent of interdisciplinary and experiential education, Dr. Shen has dedicated his career to teaching medical, engineering, and business students at Stanford and abroad in foundational concepts underpinning design-thinking, clinical immersion, ideation, rapid prototyping, innovation, and entrepreneurship. In addition, Dr. Shen is responsible for establishing and/or managing collaborations between Stanford and Biodesign-like programs on every continent except Antarctica! He continues to annually mentor diverse groups of students to develop and implement innovative medical solutions to serve patients around the world.
Dr. Shen is the founding and current U.S. Executive Director of Singapore Stanford Biodesign since its inception in 2010. As the first Biodesign program in East Asia, its mission is to train the next generation of medical technology innovators throughout the Pacific Rim, focusing on the unique medical needs in the region. Supported by Singapore's national level research institute, the Agency for Science, Technology, and Research (ASTAR), and the National Research Foundation (NRF), the program has uniquely built bridges across Asia, spanning Singapore, China, Indonesia, Taiwan, Korea, Australia, and Malaysia. In total, the program has trained 60 Fellows and hundreds of students throughout the region.
Dr. Shen is also a Partner at Novo Holdings, the asset manager of the Novo Foundation, one of the largest philanthropic organizations in the world. With headquarters in Denmark, Novo Holdings is committed to investing in innovative companies that improve the health of people and planet. Dr. Shen started his career in medical innovation as a Senior Design Engineer at Guidant Neurovascular, where he was the principal inventor of one of the original stentriever devices for ischemic stroke. He has been issued twelve patents in the fields of interventional neuroradiology and interventional cardiology.
Dr. Shen was a Stanford Asia/Pacific Scholar and a Paul & Daisy Soros Fellow. -
Fangfang Shen
Physical Science Research Scientist
Current Research and Scholarly InterestsIdentify protein inhibitors and develop novel specific protein delivery systems.
-
Jeanne Shen
Associate Professor of Pathology
Current Research and Scholarly InterestsGastrointestinal and pancreatobiliary pathology, with major emphasis on GI and pancreatic neoplasia, inflammatory bowel disease, biodesign innovation, and the application of machine learning to digital pathology.
-
Kang Shen
Vincent V.C. Woo Director, Wu Tsai Neurosciences Institute, Frank Lee and Carol Hall Professor and Professor of Biology and of Pathology
Current Research and Scholarly InterestsThe connectivity of a neuron (its unique constellation of synaptic inputs and outputs) is essential for its function. Neuronal connections are made with exquisite accuracy between specific types of neurons. How each neuron finds its synaptic partners has been a central question in developmental neurobiology. We utilize the relatively simple nervous system of nematode C. elegans, to search for molecules that can specify synaptic connections and understand the molecular mechanisms of synaptic as
-
Luyao Shen, MD
Clinical Associate Professor, Radiology
Current Research and Scholarly InterestsGU and Gyn clinical imaging
-
Sam Shen
Clinical Professor, Emergency Medicine
Current Research and Scholarly InterestsEmergency Department process improvement
Digital Health
ED operations
ED innovations -
Sandra Wright Shen
Lecturer
BioSteinway Artist Sandra Wright Shen has been described as “a classical pianist of the first order.” With her passion, musicality and inspiration, she aims to move hearts and uplift spirits through music.
Sandra has performed across 16 countries in over 600 concerts. Her appearances include prestigious venues such as the Kennedy Center in Washington, D.C., the Chicago Cultural Center, Monte Carlo Opera House, Palau de la Música Catalana in Barcelona, Frankfurt Cultural Center, the Forbidden City Concert Hall in Beijing, Taiwan National Concert Hall, Seoul Arts Center, Hong Kong City Hall, and festivals including the Granada International Music Festival, Recontres Musicales de Chaon in France, Brevard Music Festival, Tanglewood BUTI, Chelsea Music Festival, MasterWorks Festival and Steinway Society Concert Series.
She has been featured as guest artist with orchestras appearances around the world displaying a broad repertoire of 26 concertos. She served as Artist-in-Residence with the Charleston Symphony during the 2017–18 season. As a chamber musician, Sandra has performed with renowned artists including Vesselin Paraschkevov (former concertmaster of the Vienna Philharmonic), Brinton Smith (Houston Symphony), bassoonist Sergio Azzolini, and toured Asia with cellist Nina Kotova.
Sandra received first prize from several major international piano competitions, including First Prize at the 2012 France International Piano Competition, the 1997 Hilton Head International Piano Competition, the 1996 Mieczysław Munz Piano Competition, and the 1990 Taiwan National Piano Competition.
Her recordings include a debut CD featuring Rachmaninoff’s Piano Concerto No. 3 and Saint-Saëns’ Carnival of the Animals, both released by Taiwan’s Rolling Stone Music. Her latest album, Momentum, with cellist Miriam Smith, was released on Azica Records in 2022.
Sandra is a piano lecturer at the Stanford University and the piano chair at the San Francisco Conservatory of Music Pre-College Division. She has served on the faculty of the Brevard Music Festival, Tanglewood BUTI Young Artists Piano Program, Masterworks Music Festival, Music@Tetauchi, and American Fine Arts Festival in Europe and others. Previous academic appointments include Southern Illinois University and frequent invitations as Distinguished Guest Faculty at Furman University. Her students have won top prizes in competitions such as the International Piano Competition of Orléans (France), Stockholm International Piano Competition, the Chopin Foundation, Young Arts and the MTAC competitions.
Sandra performed live for WCQS Radio in Asheville, filmed a four-part television series “The Movements of the Master Composers” for Hong Kong TV and "Inspiration From Above" for US Creation TV, and hosted a classical music program for Taiwan’s IC Broadcast Radio FM97.5. Mixing music and philanthropy, Sandra has given benefit concerts for disaster victims, foster children, firefighters, music education for underprivileged children and San Jose Chamber Series.
Born in Taiwan, Sandra earned her Bachelor and Master of Music degrees in Piano Performance from the Peabody Conservatory of Music, where she studied with legendary pianist Ann Schein. Her teachers also include Zalina Gurevich and Jörg Demus.
www.sandrashen.com -
Zhi-Xun Shen
Paul Pigott Professor of Physical Sciences, Professor of Applied Physics, of Physics and Senior Fellow at the Precourt Institute for Energy
Current Research and Scholarly InterestsDr. Shen's main research interest lies in the area of condensed matter and materials physics, as well as the applications of materials and devices. He develops photon based innovative instrumentation and advanced experimental techniques, ranging from angle-resolved photoemission to microwave imaging, soft x-ray scattering and time domain spectroscopy and scattering. He has created a body of literature that advanced our understanding of quantum materials, including superconductors, semiconductors, novel magnets, topological insulators, novel carbon and electron emitters. He is best known for his discoveries of the momentum structure of anisotropic d-wave pairing gap and anomalous normal state pseudogap in high temperature superconductors. He has further leveraged the advanced characterization tool to make better materials through thin film and interface engineering.
-
Stephen Shenker
Richard Herschel Weiland Professor
Current Research and Scholarly InterestsProfessor Shenker’s research focuses on quantum gravity, in particular string theory and M theory, with an emphasis on nonperturbative aspects.
-
Krishna Shenoy
Member, Bio-X
Current Research and Scholarly InterestsWe conduct neuroscience, neuroengineering and translational research to better understand how the brain controls movement, and to design medical systems to assist people with paralysis. These are referred to as brain-machine interfaces (BMIs), brain-computer interfaces (BCIs) and intra-cortical neural prostheses. We conduct this research as part of our Neural Prosthetic Systems Lab (NPSL) and our Neural Prosthetics Translational Lab (NPTL), which I co-direct with Prof. Jaimie Henderson, M.D.
-
Sheri D. Sheppard
Richard W. Weiland Professor in the School of Engineering, Emerita
BioSheri Sheppard teaches both undergraduate and graduate design-related classes, and conducts research on fracture mechanics and applied finite element analysis, and on how people become engineers. From 1999-2008 she served as a Senior Scholar at the Carnegie Foundation for the Advancement of Teaching, leading the Foundation’s engineering study. In addition to publishing technical papers, reports, and textbooks, she has led or co-led several large, multi-institutional projects to build new educational research programs and related resources, such as the Center for the Advancement of Engineering Education (CAEE), The National Center for Engineering Pathways to Innovation (Epicenter), and a program on summer research experiences for high school teachers. Her industry experience includes engineering positions at Detroit's "Big Three” — Ford Motor Company, General Motors Corporation, and Chrysler Corporation. She earned her bachelors degree from the University of Wisconsin, and her PhD at the University of Michigan. At Stanford she has served a chair of the faculty senate, as associate vice provost for graduate education, and is the longtime faculty founder of and adviser to the graduate student group MEwomen. Her work has been recognized with numerous honors and awards, including the Walter J. Gores Award, Stanford University's highest award for excellence in teaching and the Chester F. Carlson and Ralph Coats Roe Awards of the American Society for Engineering Education in recognition of distinguished accomplishment in engineering education, and for outstanding teaching and notable contributions to the mechanical engineering profession.
-
Yelizaveta Sher, MD, FACLP
Clinical Professor, Psychiatry and Behavioral Sciences - Medical Psychiatry
Clinical Professor (By courtesy), Medicine - Pulmonary, Allergy & Critical Care MedicineBioDr. Sher received her BA from UC Berkeley and MD from Washington University in St. Louis. She completed Residency in Psychiatry and Fellowship in Psychosomatic Medicine at Stanford University Medical Center. She has been a part of Psychosomatic Medicine Faculty, now a Division of Medical Psychiatry, at Stanford since 2013. Her areas of clinical and research interests include psychiatric comorbidities in patients with pulmonary disorders. In particular, she specializes in mental health of patients with cystic fibrosis as well as lung and heart transplant patients. She consults on patients hospitalized on medical and surgical units as well as sees patients in outpatient clinics. She serves as the Director of Psychiatric and Psychological Services for the Adult Cystic Fibrosis Clinic and Chief of Psychosomatic Medicine Clinic. She has published many articles and book chapters and edited several books related to her fields of interest and expertise.
-
Gavin Sherlock
Professor of Genetics
Current Research and Scholarly InterestsEvolution and the adaptive landscape using yeast as a model; Defining yeast transcriptomes; chromosomal evolution in hybrid yeast species
-
Seth Lawrence Sherman, MD
Associate Professor of Orthopaedic Surgery
Current Research and Scholarly InterestsMy research focuses on ways to augment tissue healing, improve human performance, and prevent musculoskeletal injuries. Approaching these challenges through parallel basic science and clinical pathways, our team works from the “bedside to the bench and back to the bedside”, identifying areas of clinical need to deliver evidence-based solutions for patients.
We collaborates with orthopaedic surgeons, non-surgical physicians, and researchers within bioengineering, human performance, and musculoskeletal imaging across the Stanford campus. The team is developing novel methods to accurately record human movement (including wearable technology, phone-based systems), rapid MRI imaging protocols, and exploring the use of biomarkers to track injury and recovery. This research builds on my earlier work, which utilized portable, inexpensive software for Microsoft Kinect to detect knee injury risk in youth athletes performing a drop vertical jump test. The team’s multifaceted goal is: 1) develop innovative methods to screen for injury risk (i.e. youth athlete non-contact ACL), 2) create targeted intervention programs to reduce risk, 3) enhance athletic performance; and 4) improve accuracy of return to play testing following injury/surgery (i.e. clinical evaluation, biomarkers, functional tests, imaging analysis for healing).
In the laboratory,our team investigates cellular and molecular deficiencies in tissue types including tendon, ligament, articular cartilage, and meniscus. By understanding aberrant pathways leading to tissue injury, they can identify innovative therapeutic targets for intervention. In collaboration with the Genetic Engineering and Synthetic Biology laboratories, Dr. Sherman’s research has explored the role of orthobiologic agents such as platelet rich plasma (PRP) and bone marrow aspirate concentrate (BMAC) for tissue healing in patella tendinopathy (the breakdown of collagen in a tendon). Our lab is also investigating the use of CBD for musculoskeletal applications as an alternative to commonly used local anesthetics and cortisone derivatives. In my earlier work, we researched the cellular toxicity of such applications.
In addition to basic science research, I have helped to build a Sports Medicine clinical research team that includes several full-time clinical research coordinators, residents, fellows, and students. The team collects prospective outcomes on their patients using a novel data collection platform called Patient IQ. The group is part of the JUPITER study which is the largest, multicenter study ever assembled in patellofemoral instability. They are additionally planning to enroll in FDA-approved clinical studies investigating pioneering strategies for knee cartilage restoration, joint preservation, and orthobiologic injections for osteoarthritis. Recent clinical publications explore outcomes in meniscus preservation and transplantation, medial patellofemoral ligament reconstruction, osteochondral allograft and matrix-induced autologous chondrocyte implantation (MACI), and surgical augmentation using PRP/BMAC. The clinical research team actively reports results of non-surgical and surgical interventions to continue to introduce new knowledge to the field, with the goal of improved patient outcome.
